Stockscreener 앱 받기
40.81
0.21%
-0.15
전일 마감가:
$40.96
열려 있는:
$40.94
하루 거래량:
30,174
Relative Volume:
0.06
시가총액:
$1.99B
수익:
$447.57M
순이익/손실:
$-38.92M
주가수익비율:
-49.17
EPS:
-0.83
순현금흐름:
$-1.15M
1주 성능:
+2.52%
1개월 성능:
+25.00%
6개월 성능:
+100.96%
1년 성능:
+23.83%
1일 변동 폭
$40.73
$41.14
1주일 범위
$38.90
$41.77
52주 변동 폭
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
ATRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
40.98 | 1.99B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
588.35 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.53 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.25 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.62 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
329.75 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
Transcatheter Aortic Valve Replacement Market Future Business - openPR
AtriCure, Inc. (NASDAQ:ATRC) Shares Purchased by Calamos Advisors LLC - MarketBeat
Atrial Fibrillation Systems Market Witness Booming Demand: - openPR
AtriCure (NASDAQ:ATRC) Stock Price Down 4.9%Should You Sell? - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of “Buy” by Brokerages - Defense World
AtriCure (NASDAQ:ATRC) Sets New 1-Year HighHere's What Happened - MarketBeat
Why AtriCure, Inc. (ATRC) Is Skyrocketing Now - MSN
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 - Defense World
Trading (ATRC) With Integrated Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Hits New 52-Week High Following Analyst Upgrade - MarketBeat
Needham reiterates Buy on AtriCure shares amid impressive growth and solid valuation - MSN
Revenues Tell The Story For AtriCure, Inc. (NASDAQ:ATRC) As Its Stock Soars 29% - Simply Wall St
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at Needham & Company LLC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results - Business Wire
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) - Benzinga
Assenagon Asset Management S.A. Has $4.25 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
Assenagon Asset Management S.A. Sells 90,029 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Atrial Fibrillation Surgery Market Trends & Insights 2025 -2033 - openPR
AtriCure stock soars to 52-week high, hits $39.08 - MSN
Orthofix Medical (NASDAQ:OFIX) vs. AtriCure (NASDAQ:ATRC) Head-To-Head Contrast - Defense World
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighShould You Buy? - MarketBeat
AtriCure stock soars to 52-week high, hits $39.08 By Investing.com - Investing.com South Africa
AtriCure reports preliminary results for fourth quarter - MSN
AtriCure (ATRC) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by JPMorgan Chase & Co. - MarketBeat
AtriCure projects growth, sets 2025 financial targets By Investing.com - Investing.com Australia
AtriCure projects growth, sets 2025 financial targets - Investing.com
Needham retains AtriCure stock buy rating after revenue beat By Investing.com - Investing.com Australia
AtriCure Q4 revenue prelims beat The Street - Mass Device
Long Term Trading Analysis for (ATRC) - Stock Traders Daily
AtriCure Inc (ATRC) Shares Up 5.13% on Jan 13 - GuruFocus.com
AtriCure (NASDAQ:ATRC) Shares Gap UpShould You Buy? - MarketBeat
AtriCure's (ATRC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham retains AtriCure stock buy rating after revenue beat - Investing.com India
AtriCure (NASDAQ:ATRC) Issues FY 2024 Earnings Guidance - MarketBeat
AtriCure Projects Strong Revenue Growth for 2024 - TipRanks
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of “Buy” by Analysts - Defense World
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
0.62%
자본화:
|
볼륨(24시간):